3rd Quarter - Report

REM STRATEGIES, LLC for A.P. GOLDSHIELD LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 18, 2022 $10,000 Replaced
3rd Quarter - Amendment Oct 18, 2022 $10,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

pursuing registration clarification for antimicrobial products with FDA and EPA. Seeking approval from EPA for antiviral textile protocol developed by client. Looking to assist Smithsonian Institution to mitigate mold health related issues in those museums and galleries.

LobbyistCovered position, as disclosed
ROBERT E. MILLS lobbyist, President REM Strategies LLC

Contacted: Food & Drug Administration (FDA); Smithsonian Institution; Environmental Protection Agency (EPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.